FHIR IG analytics| Package | hl7.terminology |
| Resource Type | CodeSystem |
| Id | CodeSystem-detectedissue-clinical-impact.json |
| FHIR Version | R5 |
| Source | https://build.fhir.org/ig/HL7/UTG/CodeSystem-detectedissue-clinical-impact.html |
| URL | http://terminology.hl7.org/CodeSystem/detectedissue-clinical-impact |
| Version | 1.0.0 |
| Status | active |
| Date | 2026-09-14 |
| Name | DetectedIssueClinicalImpact |
| Title | Detected Issue Clinical Impact |
| Realm | uv |
| Authority | hl7 |
| Description | Codes that describe the potential clinical impact of a detected issue. |
| Copyright | This material derives from the HL7 Terminology (THO). THO is copyright ©1989+ Health Level Seven International and is made available under the CC0 designation. For more licensing information see: https://terminology.hl7.org/license |
| Content | complete |
| ValueSet | ||
| hl7.terminology#current | detectedissue-clinical-impact | Detected Issue Clinical Impact |
No resources found
Note: links and images are rebased to the (stated) source
Generated Narrative: CodeSystem detectedissue-clinical-impact
This case-sensitive code system http://terminology.hl7.org/CodeSystem/detectedissue-clinical-impact defines the following codes:
{
"resourceType": "CodeSystem",
"id": "detectedissue-clinical-impact",
"text": {
"status": "generated",
"div": "<!-- snip (see above) -->"
},
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-wg",
"valueCode": "cds"
},
{
"url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-standards-status",
"valueCode": "trial-use"
},
{
"url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-fmm",
"valueInteger": 3
}
],
"url": "http://terminology.hl7.org/CodeSystem/detectedissue-clinical-impact",
"version": "1.0.0",
"name": "DetectedIssueClinicalImpact",
"title": "Detected Issue Clinical Impact",
"status": "active",
"experimental": false,
"date": "2026-09-14",
"publisher": "Health Level Seven International",
"contact": [
{
"telecom": [
{
"system": "url",
"value": "http://hl7.org"
},
{
"system": "email",
"value": "hq@HL7.org"
}
]
}
],
"description": "Codes that describe the potential clinical impact of a detected issue.",
"copyright": "This material derives from the HL7 Terminology (THO). THO is copyright ©1989+ Health Level Seven International and is made available under the CC0 designation. For more licensing information see: https://terminology.hl7.org/license",
"caseSensitive": true,
"valueSet": "http://terminology.hl7.org/ValueSet/detectedissue-clinical-impact",
"content": "complete",
"concept": [
{
"code": "increased-effect",
"display": "Increased effect",
"definition": "The clinical or pharmacologic effect is expected to be increased for one or more implicated therapies."
},
{
"code": "decreased-effect",
"display": "Decreased effect",
"definition": "The clinical or pharmacologic effect is expected to be decreased for one or more implicated therapies."
},
{
"code": "mixed-effect",
"display": "Mixed effect",
"definition": "Mixed or differing changes in clinical or pharmacologic effects are expected."
},
{
"code": "adverse-reaction",
"display": "Adverse reaction",
"definition": "An adverse reaction is expected or its risk is increased."
},
{
"code": "additive-adverse-effects",
"display": "Additive adverse effects",
"definition": "Adverse or undesirable effects are expected to be additive for one or more implicated therapies."
},
{
"code": "avoid-concurrent-use",
"display": "Avoid concurrent use when possible",
"definition": "Concurrent use should generally be avoided because of the identified clinical risk."
},
{
"code": "contraindicated-in-some-patients",
"display": "Contraindicated in some patients",
"definition": "Concurrent use is contraindicated for a subset of patients based on patient-specific clinical characteristics or circumstances."
}
]
}